{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:02:34Z","timestamp":1792526554362,"version":"4.5.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","gastrojournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1053\/j.gastro.2021.09.076","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T04:02:07Z","timestamp":1641268927000},"page":"1424-1438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Evolving Short- and Long-Term Goals of Management of Inflammatory Bowel Diseases: Getting It Right, Making It Last"],"prefix":"10.1053","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1124-2019","authenticated-orcid":false,"given":"Catherine","family":"Le Berre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ricciuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2021.09.076_bib1","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/ibd.21506","article-title":"Development of the Crohn\u2019s disease digestive damage score, the L\u00e9mann Score","volume":"17","author":"Pariente","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib2","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2021.09.076_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","article-title":"Crohn\u2019s disease","volume":"6","author":"Roda","year":"2020","journal-title":"Nat Rev Dis Primer"},{"key":"10.1053\/j.gastro.2021.09.076_bib4","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/ibd.22839","article-title":"Ulcerative colitis as a progressive disease: the forgotten evidence","volume":"18","author":"Torres","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat Rev Dis Primer"},{"key":"10.1053\/j.gastro.2021.09.076_bib6","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.cgh.2021.01.028","article-title":"Incidence of and risk factors for colorectal strictures in ulcerative colitis: a multicenter study","volume":"19","author":"Laurain","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.076_bib8","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2021.09.076_bib9","first-page":"439","article-title":"Development and validation of a pediatric Crohn\u2019s disease activity index","volume":"12","author":"Hyams","year":"1991","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2021.09.076_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","article-title":"Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study","volume":"133","author":"Turner","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.076_bib11","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/gut.2010.234617","article-title":"Surgery for adult Crohn\u2019s disease: what is the actual risk?","volume":"60","author":"Bouguen","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.09.076_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/gutjnl-2013-304984","article-title":"Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn\u2019s disease in the SONIC trial","volume":"63","author":"Peyrin-Biroulet","year":"2014","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.09.076_bib13","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0140-6736(15)00068-9","article-title":"Early combined immunosuppression for the management of Crohn\u2019s disease (REACT): a cluster randomised controlled trial","volume":"386","author":"Khanna","year":"2015","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2021.09.076_bib14","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.076_bib15","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib16","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn\u2019s disease (CALM): a multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2018","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2021.09.076_bib17","first-page":"S24","article-title":"OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn\u2019s disease: long-term data from CALM","volume":"13","author":"Yzet","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-Reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.cgh.2018.01.024","article-title":"Associations among mucosal and transmural healing and fecal level of calprotectin in children with Crohn\u2019s disease","volume":"16","author":"Weinstein-Nakar","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ibd.21355","article-title":"Crohn\u2019s disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection","volume":"17","author":"Regueiro","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib21","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.cgh.2016.01.015","article-title":"Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis","volume":"14","author":"Shah","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/apt.13475","article-title":"Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn\u2019s disease","volume":"43","author":"Shah","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.09.076_bib23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/gut.30.7.983","article-title":"Development and validation of an endoscopic index of the severity for Crohn\u2019s disease: a prospective multicentre study. Groupe d\u2019Etudes Th\u00e9rapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)","volume":"30","author":"Mary","year":"1989","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.09.076_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: the SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.gastro.2021.09.076_bib25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/gutjnl-2011-300486","article-title":"Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)","volume":"61","author":"Travis","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.09.076_bib26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.gastro.2013.07.024","article-title":"Reliability and initial validation of the ulcerative colitis endoscopic index of severity","volume":"145","author":"Travis","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.076_bib27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/ecco-jcc\/jjv210","article-title":"The Ulcerative Colitis Endoscopic Index of Severity more accurately reflects clinical outcomes and long-term prognosis than the Mayo Endoscopic Score","volume":"10","author":"Ikeya","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib28","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/gutjnl-2015-309903","article-title":"IOIBD technical review on endoscopic indices for Crohn\u2019s disease clinical trials","volume":"65","author":"Vuitton","year":"2016","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.09.076_bib29","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/gutjnl-2014-308839","article-title":"An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitis","volume":"64","author":"Manginot","year":"2015","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.09.076_bib30","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1053\/j.gastro.2020.06.043","article-title":"Incremental benefit of achieving endoscopic and histologic remission in patients with ulcerative colitis: a systematic review and meta-analysis","volume":"159","author":"Yoon","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.076_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/ecco-jcc\/jjaa176","article-title":"Clinical, endoscopic and histological outcomes in induction of moderate-to-severe ulcerative colitis: a systematic review with meta-analysis","volume":"15","author":"Magro","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.10.016","article-title":"Agreement between rectosigmoidoscopy and colonoscopy analyses of disease activity and healing in patients with ulcerative colitis","volume":"150","author":"Colombel","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.076_bib33","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/apt.16310","article-title":"Pancolonic endoscopic and histologic evaluation for relapse prediction in patients with ulcerative colitis in clinical remission","volume":"53","author":"Kaneshiro","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.09.076_bib34","doi-asserted-by":"crossref","first-page":"S049","DOI":"10.1093\/ecco-jcc\/jjz203.052","article-title":"DOP13 Clinical and endoscopic response to ustekinumab in Crohn\u2019s disease: week 16 interim analysis of the STARDUST trial","volume":"14","author":"Danese","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib35","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.3748\/wjg.v25.i31.4534","article-title":"Small bowel capsule endoscopy and treat-to-target in Crohn\u2019s disease: a systematic review","volume":"25","author":"le Berre","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib36","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","article-title":"Ustekinumab as induction and maintenance therapy for ulcerative colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2021.09.076_bib37","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.cgh.2020.09.046","article-title":"Treat to target: the role of histologic healing in inflammatory bowel diseases: a systematic review and meta-analysis","volume":"19","author":"Gupta","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib38","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1053\/j.gastro.2007.08.001","article-title":"Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study","volume":"133","author":"Gupta","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.076_bib39","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/MIB.0000000000001143","article-title":"Transmural healing is associated with improved long-term outcomes of patients with Crohn\u2019s disease","volume":"23","author":"Fernandes","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib40","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/apt.15190","article-title":"One-year clinical outcomes with biologics in Crohn\u2019s disease: transmural healing compared with mucosal or no healing","volume":"49","author":"Castiglione","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.09.076_bib41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/apt.16248","article-title":"An expert consensus to standardise the assessment of histological disease activity in Crohn\u2019s disease clinical trials","volume":"53","author":"Almradi","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.09.076_bib42","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1053\/j.gastro.2021.02.035","article-title":"An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials","volume":"160","author":"Ma","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.076_bib43","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/gut.2008.167957","article-title":"Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn\u2019s disease","volume":"58","author":"Rimola","year":"2009","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.09.076_bib44","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/j.gastro.2019.03.051","article-title":"Development and validation of a simplified magnetic resonance index of activity for Crohn\u2019s disease","volume":"157","author":"Ord\u00e1s","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.076_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00247-017-3790-4","article-title":"Magnetic resonance enterography has good inter-rater agreement and diagnostic accuracy for detecting inflammation in pediatric Crohn disease","volume":"47","author":"Church","year":"2017","journal-title":"Pediatr Radiol"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2021.09.076_bib46","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1093\/ecco-jcc\/jjx180.255","article-title":"P128 Development of the Paediatric Inflammatory Crohn\u2019s MRE Index (PICMI)\u2014results from the ImageKids Study","volume":"12","author":"Turner","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1148\/radiol.2361040799","article-title":"Role of US in detection of Crohn disease: meta-analysis","volume":"236","author":"Fraquelli","year":"2005","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2021.09.076_bib48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cgh.2016.10.040","article-title":"Use of intestinal ultrasound to monitor Crohn\u2019s disease activity","volume":"15","author":"Kucharzik","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib49","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/MIB.0000000000001174","article-title":"A\u00a0simple ultrasound score for the accurate detection of inflammatory activity in Crohn\u2019s disease","volume":"23","author":"Novak","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.dld.2019.10.004","article-title":"Impact of intestinal ultrasound on the management of patients with inflammatory bowel disease: how to apply scientific evidence to clinical practice","volume":"52","author":"Fraquelli","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib51","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/ecco-jcc\/jjy107","article-title":"Accuracy of Humanitas Ultrasound Criteria in assessing disease activity and severity in ulcerative colitis: a prospective study","volume":"12","author":"Allocca","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006951","article-title":"I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment","volume":"15","author":"Pavlidis","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"10.1053\/j.gastro.2021.09.076_bib53","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000134","article-title":"MicroRNA-320a monitors intestinal disease activity in patients with inflammatory bowel disease","volume":"11","author":"Cordes","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/apt.14384","article-title":"Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management","volume":"47","author":"McIlroy","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.09.076_bib55","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jalz.2008.12.003","article-title":"Defining and labeling disease-modifying treatments for Alzheimer\u2019s disease","volume":"5","author":"Cummings","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.1053\/j.gastro.2021.09.076_bib56","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(57)90667-0","article-title":"The natural history of ulcerative colitis","volume":"272","author":"Cullinan","year":"1957","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2021.09.076_bib57","first-page":"258","article-title":"The natural history and treatment of Crohn\u2019s disease","volume":"36","author":"Schofield","year":"1965","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1053\/j.gastro.2021.09.076_bib58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ajg.2009.579","article-title":"The natural history of adult Crohn\u2019s disease in population-based cohorts","volume":"105","author":"Peyrin-Biroulet","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cgh.2017.06.016","article-title":"Natural History of adult ulcerative colitis in population-based cohorts: a systematic review","volume":"16","author":"Fumery","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib60","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/ibd\/izy374","article-title":"A\u00a010-year follow-up study of the natural history of perianal Crohn\u2019s disease in a Danish population-based inception cohort","volume":"25","author":"Zhao","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib61","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/ajg.2009.177","article-title":"The natural history of pediatric ulcerative colitis: a population-based cohort study","volume":"104","author":"Gower-Rousseau","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib62","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apt.13478","article-title":"Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies","volume":"43","author":"Fumery","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.09.076_bib63","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ibd\/izaa080","article-title":"Natural history of very early onset inflammatory bowel disease in North America: a retrospective cohort study","volume":"27","author":"Kerur","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib64","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/MIB.0000000000000821","article-title":"Natural history of Crohn\u2019s disease in elderly patients diagnosed over the age of 70 years: a population-based study","volume":"22","author":"Fumery","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib65","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/ecco-jcc\/jjv194","article-title":"Natural history of elderly-onset ulcerative colitis: results from a territory-wide inflammatory bowel disease registry","volume":"10","author":"Shi","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib66","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/apt.14494","article-title":"Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study","volume":"47","author":"Ma\u00f1osa","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.09.076_bib67","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/ecco-jcc\/jjaa181","article-title":"Epidemiology and natural history of elderly-onset inflammatory bowel disease: results from a territory-wide Hong Kong IBD registry","volume":"15","author":"Mak","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib68","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/ecco-jcc\/jjv080","article-title":"Bowel damage as assessed by the L\u00e9mann Index is reversible on anti-TNF therapy for Crohn\u2019s disease","volume":"9","author":"Fiorino","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177479","article-title":"Early anti-TNF\/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn\u2019s disease with poor prognostic factors","volume":"12","author":"Oh","year":"2017","journal-title":"PloS One"},{"key":"10.1053\/j.gastro.2021.09.076_bib70","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1007\/s10620-018-5434-4","article-title":"Earlier anti-tumor necrosis factor therapy of Crohn\u2019s disease correlates with slower progression of bowel damage","volume":"64","author":"Panchal","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2021.09.076_bib71","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/MIB.0000000000000679","article-title":"Anti-TNF therapy within 2 years of Crohn\u2019s disease diagnosis improves patient outcomes: a retrospective cohort study","volume":"22","author":"Ma","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/ecco-jcc\/jjv187","article-title":"Timing of thiopurine or anti-TNF initiation is associated with the risk of major abdominal surgery in Crohn\u2019s disease: a retrospective cohort study","volume":"10","author":"Gonz\u00e1lez-Lama","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib73","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3904\/kjim.2020.001","article-title":"Impact of early anti-TNF use on clinical outcomes in Crohn\u2019s disease: a nationwide population-based study","volume":"35","author":"Jung","year":"2020","journal-title":"Korean J Intern Med"},{"key":"10.1053\/j.gastro.2021.09.076_bib74","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.dld.2014.07.168","article-title":"Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: results from two referral centres","volume":"46","author":"Mandel","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib75","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1080\/00365521.2018.1495258","article-title":"Regional differences in anti-TNF-\u03b1 therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study","volume":"53","author":"Lirhus","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib76","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/00365521.2019.1620326","article-title":"Impact of anti\u2013TNF-alpha therapy on colectomy rate and indications for colectomy in ulcerative colitis: comparison of two patient cohorts from 2005 to 2007 and from 2014 to 2016","volume":"54","author":"Kolehmainen","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib77","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S2468-1253(17)30248-0","article-title":"Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn\u2019s disease: a randomised controlled, open-label, multicentre trial","volume":"2","author":"Ponsioen","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib78","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/gutjnl-2018-317539","article-title":"Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn\u2019s disease: the LIR!C trial","volume":"68","author":"Groof EJ de","year":"2019","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.09.076_bib79","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S2468-1253(20)30117-5","article-title":"Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn\u2019s disease: retrospective long-term follow-up of the LIR!C trial","volume":"5","author":"Stevens","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib80","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.gastro.2020.10.065","article-title":"Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT Consensus from the IOIBD","volume":"160","author":"le Berre","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.076_bib81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004836-199201000-00005","article-title":"Quality of life in inflammatory bowel disease","volume":"14","author":"Love","year":"1992","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib82","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000016938","article-title":"Impact of inflammatory bowel disease on health-related quality of life","volume":"17","author":"Casellas","year":"1999","journal-title":"Dig Dis Basel Switz"},{"key":"10.1053\/j.gastro.2021.09.076_bib83","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1053\/j.gastro.2021.09.076_bib84","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/00207411.1994.11449283","article-title":"The SF-36 Health Survey: development and use in mental health research and the IQOLA Project","volume":"23","author":"Ware","year":"1994","journal-title":"Int J Ment Health"},{"key":"10.1053\/j.gastro.2021.09.076_bib85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy Amst Neth"},{"key":"10.1053\/j.gastro.2021.09.076_bib86","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0016-5085(89)90905-0","article-title":"A\u00a0new measure of health status for clinical trials in inflammatory bowel disease","volume":"96","author":"Guyatt","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.076_bib87","first-page":"1571","article-title":"The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. Canadian Crohn\u2019s Relapse Prevention Trial","volume":"91","author":"Irvine","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib88","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.crohns.2010.07.006","article-title":"Cutoff values of the Inflammatory Bowel Disease Questionnaire to predict a normal health-related quality of life","volume":"4","author":"Huam\u00e1n","year":"2010","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib89","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.crohns.2012.01.019","article-title":"Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNF\u03b1 treatment","volume":"6","author":"Casellas","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib90","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/MEG.0b013e32835414b2","article-title":"Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease","volume":"24","author":"Casellas","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib91","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","article-title":"SF-36 Health Survey update","volume":"25","author":"Ware","year":"2000","journal-title":"Spine"},{"key":"10.1053\/j.gastro.2021.09.076_bib93","first-page":"303","article-title":"The International Classification of Functioning Disability and Health: its development process and content validity","volume":"44","author":"Cieza","year":"2008","journal-title":"Eur J Phys Rehabil Med"},{"key":"10.1053\/j.gastro.2021.09.076_bib94","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ibd.21010","article-title":"Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health","volume":"16","author":"Peyrin-Biroulet","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib95","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/gutjnl-2011-300049","article-title":"Development of the first disability index for inflammatory bowel disease based on the International Classification of Functioning, Disability and Health","volume":"61","author":"Peyrin-Biroulet","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.09.076_bib96","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/gutjnl-2015-310151","article-title":"Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort","volume":"66","author":"Gower-Rousseau","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.09.076_bib97","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/ibd\/izx063","article-title":"Independent validation of a self-report version of the IBD Disability Index (IBDDI) in a population-based cohort of IBD patients","volume":"24","author":"Shafer","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib98","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MIB.0000000000001033","article-title":"Development of the IBD Disk: a visual self-administered tool for assessing disability in inflammatory bowel diseases","volume":"23","author":"Ghosh","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib99","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/ecco-jcc\/jjaa100","article-title":"Validation of the IBD-Disk instrument for assessing disability in inflammatory bowel diseases in a French cohort: the VALIDATE study","volume":"14","author":"Le Berre","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib100","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/ecco-jcc\/jjaa244","article-title":"The IBD-Disk is a reliable tool to assess the daily-life burden of patients with inflammatory bowel disease","volume":"15","author":"Tadbiri","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib101","first-page":"55","article-title":"The introduction of the IBD Disk in Poland\u2014a new tool for assessing disability in patients with inflammatory bowel disease","volume":"15","author":"Eder","year":"2020","journal-title":"Przeglad Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib102","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1097\/00007632-200012150-00014","article-title":"Guidelines for the process of cross-cultural adaptation of self-report measures","volume":"25","author":"Beaton","year":"2000","journal-title":"Spine"},{"key":"10.1053\/j.gastro.2021.09.076_bib103","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ecco-jcc\/jjw145","article-title":"Patient-reported outcomes in a french nationwide survey of inflammatory bowel disease patients","volume":"11","author":"Williet","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib104","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/ibd\/izx109","article-title":"Fecal incontinence in inflammatory bowel disease: a systematic review and meta-analysis","volume":"24","author":"Gu","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02050307","article-title":"Etiology and management of fecal incontinence","volume":"36","author":"Jorge","year":"1993","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2021.09.076_bib106","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cgh.2015.12.045","article-title":"Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease","volume":"14","author":"Mikocka-Walus","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib107","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/MIB.0b013e31827f278e","article-title":"Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the Swiss Inflammatory Bowel Disease Cohort Study","volume":"19","author":"Siebert","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib108","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1365-2036.2011.04871.x","article-title":"Validation of the Functional Assessment of Chronic Illness Therapy\u2014Fatigue (FACIT-F) in patients with inflammatory bowel disease","volume":"34","author":"Tinsley","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.09.076_bib109","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","article-title":"Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system","volume":"13","author":"Yellen","year":"1997","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1053\/j.gastro.2021.09.076_bib110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1053\/j.gastro.2021.09.076_bib111","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"10.1053\/j.gastro.2021.09.076_bib112","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.clinthera.2008.02.016","article-title":"Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn\u2019s disease","volume":"30","author":"Reilly","year":"2008","journal-title":"Clin Ther"},{"key":"10.1053\/j.gastro.2021.09.076_bib113","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2014.09.015","article-title":"Development of the L\u00e9mann Index to assess digestive tract damage in patients with Crohn\u2019s disease","volume":"148","author":"Pariente","year":"2015","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2021.09.076_bib114","first-page":"S5","article-title":"OP05 Validation of the L\u00e9mann index in Crohn\u2019s disease","volume":"14","author":"Pariente","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.09.076_bib115","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.cgh.2015.02.041","article-title":"Changes in the L\u00e9mann Index values during the first years of Crohn\u2019s disease","volume":"13","author":"Gilletta","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib116","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MCG.0000000000000463","article-title":"Delineation of Crohn\u2019s disease trajectories using change in L\u00e9mann Index: a natural history study","volume":"50","author":"Bhagya Rao","year":"2016","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib117","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bpg.2016.02.011","article-title":"Definitions of intestinal failure and the short bowel syndrome","volume":"30","author":"Pironi","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2021.09.076_bib118","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/ajg.2012.117","article-title":"Development of the Paris definition of early Crohn\u2019s disease for disease-modification trials: results of an international expert opinion process","volume":"107","author":"Peyrin-Biroulet","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"1 Suppl 1","key":"10.1053\/j.gastro.2021.09.076_bib119","first-page":"S24","article-title":"Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study","author":"Comi","year":"1995","journal-title":"Mult Scler"},{"key":"10.1053\/j.gastro.2021.09.076_bib120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00019052-200006000-00001","article-title":"Why treat early multiple sclerosis patients?","volume":"13","author":"Comi","year":"2000","journal-title":"Curr Opin Neurol"},{"key":"10.1053\/j.gastro.2021.09.076_bib121","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1177\/1352458509107007","article-title":"Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode","volume":"15","author":"Goodin","year":"2009","journal-title":"Mult Scler"},{"key":"10.1053\/j.gastro.2021.09.076_bib122","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(09)70237-6","article-title":"Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial","volume":"8","author":"Kappos","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.gastro.2021.09.076_bib123","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1177\/1352458516675039","article-title":"Importance of early treatment initiation in the clinical course of multiple sclerosis","volume":"23","author":"Kavaliunas","year":"2017","journal-title":"Mult Scler"},{"key":"10.1053\/j.gastro.2021.09.076_bib124","first-page":"701","article-title":"The long-term impact of early treatment of multiple sclerosis on the risk of disability pension","volume":"265","author":"Landfeldt","year":"2018","journal-title":"J\u00a0Neurol"},{"key":"10.1053\/j.gastro.2021.09.076_bib125","article-title":"Importance of early treatment decisions on future income of multiple sclerosis patients","volume":"6","author":"Kavaliunas","year":"2020","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1053\/j.gastro.2021.09.076_bib126","first-page":"308","article-title":"Long-term follow-up of multiple sclerosis studies and outcomes from early treatment of clinically isolated syndrome in the BENEFIT 11 study","volume":"267","author":"Hartung","year":"2020","journal-title":"J\u00a0Neurol"},{"key":"10.1053\/j.gastro.2021.09.076_bib127","doi-asserted-by":"crossref","DOI":"10.1177\/13524585211010128","article-title":"Early treatment delays long-term disability accrual in RRMS: results from the BMSD network","author":"Iaffaldano","year":"2021","journal-title":"Mult Scler"},{"key":"10.1053\/j.gastro.2021.09.076_bib128","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.gastro.2021.09.076_bib129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/rheumatology\/kep331","article-title":"A\u00a0systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis","volume":"49","author":"Ma","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.gastro.2021.09.076_bib130","first-page":"S249","article-title":"Aggressive treatment of early rheumatoid arthritis: recognizing the window of opportunity and treating to target goals","volume":"16","author":"Resman-Targoff","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1053\/j.gastro.2021.09.076_bib131","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3899\/jrheum.131253","article-title":"Report from the OMERACT Hand Osteoarthritis Special Interest Group: advances and future research priorities","volume":"41","author":"Kloppenburg","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib132","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3899\/jrheum.141017","article-title":"Report from the OMERACT Hand Osteoarthritis Working Group: set of core domains and preliminary set of instruments for use in clinical trials and observational studies","volume":"42","author":"Kloppenburg","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib133","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3899\/jrheum.161111","article-title":"Validating rheumatoid arthritis remission using the patients\u2019 perspective: results from a special interest group at OMERACT 2016","volume":"44","author":"Rasch","year":"2017","journal-title":"J\u00a0Rheumatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib134","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/ard.2008.100271","article-title":"Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative","volume":"68","author":"Gossec","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib135","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/ard.2010.142901","article-title":"Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative","volume":"70","author":"Gossec","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib136","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/acr.20282","article-title":"Measuring fatigue in rheumatoid arthritis: a cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional questionnaire, visual analog scales, and numerical rating scales","volume":"62","author":"Nicklin","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1053\/j.gastro.2021.09.076_bib137","first-page":"789","article-title":"The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales","volume":"9","author":"Fries","year":"1982","journal-title":"J\u00a0Rheumatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib138","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/rheumatology\/keq424","article-title":"The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study","volume":"50","author":"Kyburz","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.gastro.2021.09.076_bib139","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10067-013-2325-0","article-title":"Improved radiological outcome of rheumatoid arthritis: the importance of early treatment with methotrexate in the era of biological drugs","volume":"32","author":"Fiehn","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib140","first-page":"1065","article-title":"Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials","volume":"34","author":"Levitsky","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib141","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1874312901711010136","article-title":"Long-term outcomes in Puerto Ricans with rheumatoid arthritis (RA) receiving early treatment with disease-modifying anti-rheumatic drugs using the American College of Rheumatology definition of early RA","volume":"11","author":"Varela-Rosario","year":"2017","journal-title":"Open Rheumatol J"},{"key":"10.1053\/j.gastro.2021.09.076_bib142","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.40090","article-title":"Twenty-year outcome and association between early treatment and mortality and disability in an inception cohort of patients with rheumatoid arthritis: results from the Norfolk Arthritis Register","volume":"69","author":"Gwinnutt","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1053\/j.gastro.2021.09.076_bib143","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/1756-185X.12877","article-title":"Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5-year longitudinal study of rheumatoid arthritis patients in the National Database of\u00a0Rheumatic Diseases in Japan","volume":"21","author":"Hirata","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib144","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ibd.21815","article-title":"Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts","volume":"18","author":"Magro","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib145","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/j.gastro.2011.06.054","article-title":"Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis","volume":"141","author":"Colombel","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.09.076_bib146","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ibd\/izy219","article-title":"Early mucosal healing predicts favorable outcomes in patients with moderate to severe ulcerative colitis treated with golimumab: data from the real-life BE-SMART cohort","volume":"25","author":"Bossuyt","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.09.076_bib147","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cgh.2013.09.006","article-title":"Treat to target: a proposed new paradigm for the management of Crohn\u2019s disease","volume":"13","author":"Bouguen","year":"2015","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521040671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521040671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T12:30:56Z","timestamp":1718022656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508521040671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":146,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0016508521040671"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2021.09.076","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving Short- and Long-Term Goals of Management of Inflammatory Bowel Diseases: Getting It Right, Making It Last","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2021.09.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the AGA Institute","name":"copyright","label":"Copyright"}]}}